rs34903499 — VIP

VIP Coding Variant — When the Synchronizer Peptide Itself Varies

Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide produced by a prepropeptide precursor¹¹ prepropeptide precursor
The VIP gene encodes a 170-amino-acid precursor that is processed into two bioactive peptides: VIP (residues 125–152) and PHM-27 (residues 81–107). Both are released from the same neurons and released primarily by a subset of neurons in the suprachiasmatic nucleus (SCN)²² suprachiasmatic nucleus (SCN)
The master circadian pacemaker in the hypothalamus, housing ~20,000 neurons that generate and coordinate ~24-hour biological rhythms. VIP neurons make up approximately 10% of SCN neurons and project extensively within the nucleus to synchronize neighboring cellular clocks. rs34903499 is a coding variant in the VIP gene itself — a synonymous change at codon 133 (Asn133Asn) — meaning the amino acid sequence of the final peptide is unchanged, but the altered codon can affect mRNA secondary structure, translation efficiency, and potentially pre-mRNA splicing.

While the related regulatory variant rs9479402 (~54 kb downstream of VIP) has been identified as a genome-wide significant chronotype locus in studies of nearly 700,000 individuals, rs34903499 represents a direct change within the coding sequence and operates through a different mechanism: not by altering how much VIP is transcribed in regulatory neurons, but potentially by altering how efficiently the VIP mRNA is translated into peptide. The T allele at this position is rare globally (~1–3% in most populations) and is most prevalent in African (~3%) and Ashkenazi Jewish (~5.6%) populations.

The Mechanism

Synonymous variants are no longer considered biologically inert. The codon change at position 133 alters the codon usage frequency³³ codon usage frequency
Different codons encoding the same amino acid are decoded at different speeds by the ribosome, depending on the abundance of the corresponding tRNA. Rare codons slow ribosome elongation, which can affect co-translational protein folding, mRNA stability through altered ribosome occupancy, and even splicing by changing the speed of transcription across splice sites. In a neuropeptide like VIP, where the mature peptide is produced by precise proteolytic processing of the 170-amino-acid prepropeptide, even modest changes in translation rate or processing efficiency could reduce the amount of mature VIP released per secretory event. VIP neurons release this peptide in a circadian-phase- dependent burst to synchronize neighboring SCN cells via the VPAC2 receptor and downstream cAMP-CREB signaling. Reduced burst amplitude would attenuate the coupling signal that keeps ~20,000 individual cellular clocks entrained to each other.

Beyond the SCN, VIP is expressed in the gut (where it regulates smooth muscle relaxation and secretion), in immune cells (where it suppresses pro-inflammatory cytokine release and promotes regulatory T-cell differentiation), and in peripheral neurons throughout the autonomic nervous system. A systemic reduction in VIP signaling efficiency thus has pleiotropic effects that extend beyond circadian timing to gut motility, inflammatory tone, and neuroimmune regulation.

The Evidence

VIP is non-redundant for SCN synchrony. Aton et al.⁴⁴ Aton et al.
Aton SJ et al. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci, 2005 demonstrated that VIP-null mice placed in constant darkness fragment into arrhythmic behavior within days, with individual SCN neurons drifting to their own free-running periods rather than maintaining a synchronized tissue-level rhythm. This establishes VIP as a non-redundant intercellular coupling signal — no other molecule substitutes for it in driving network-level rhythmicity.

The VIP/VPAC2 axis drives behavioral circadian rhythmicity. Harmar et al.⁵⁵ Harmar et al.
Harmar AJ et al. The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell, 2002 showed that mice lacking the VPAC2 receptor — the primary VIP receptor in the SCN — lose circadian locomotor rhythmicity under constant conditions, phenocopying the VIP-null result. This identifies the VIP→VPAC2→cAMP→CREB→Per1 cascade as the key intercellular synchronization pathway.

Human VIP variation influences chronotype at the population level. Hu et al.⁶⁶ Hu et al.
Hu Y et al. GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person. Nat Commun, 2016 identified a regulatory variant near VIP (rs9479402) as one of only seven chronotype hits at established circadian genes (P=3.9×10⁻¹¹), confirming that the level of functional VIP signaling in human SCN neurons is a determinant of whether someone is naturally a morning or evening person.

VIP as a systemic anti-inflammatory signal. VIP suppresses TNF-α, IL-6, and IL-12 production by activated macrophages and dendritic cells while promoting IL-10 and TGF-β1 release — a shift from a Th1 pro-inflammatory state toward a Th2/regulatory phenotype. This circuit operates primarily through VPAC1 receptors on immune cells and connects circadian-regulated VIP release in the SCN to daily oscillations in immune inflammatory tone. A variant reducing VIP peptide output or efficiency may thus modestly blunt this anti- inflammatory brake, particularly during the nocturnal release window when VIP peaks in the SCN.

Practical Actions

The T allele carrier should understand two implications. First, the potential for mildly reduced VIP peptide efficiency in the SCN may subtly weaken circadian coupling — the same basic vulnerability as the regulatory variant rs9479402, but acting via a different molecular step. Zeitgeber reinforcement (morning bright light, consistent meal timing, fixed wake time) compensates by maximizing the external synchronization signal at a time when the internal coupling signal may be slightly attenuated.

Second, VIP is the body's principal neuroimmune anti-inflammatory signal between the central clock and the peripheral immune system. Reduced VIP efficiency may slightly increase baseline inflammatory tone during the nocturnal window when VIP normally suppresses innate immune activity. Circadian-consistent behaviors that support VIP release timing (anchored sleep-wake cycle, avoiding nocturnal light disruption) also serve the immune regulatory arm.

Interactions

rs34903499 (coding efficiency) and rs9479402 (regulatory output) affect VIP signaling at two different levels — one upstream (transcription in regulatory neurons), one downstream (translation rate and peptide efficiency). Carrying the risk allele at both could compound reduced effective VIP in the SCN, though no published study has yet quantified the combined effect in humans. The VPAC2 receptor variant rs237902 is a third pathway partner: VIP peptide output (this SNP) × receptor sensitivity (rs237902) × SCN coupling efficiency (rs9479402) form a tripartite axis that together determines how robustly the circadian network synchronizes.